Answers are grounded in this paper and cite their sources.
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of diverse autoantibodies with various systemic organ involvements. In patients with SLE, autoantibodies, such as antinuclear antibody (ANA) and anti-dsDNA antibody, play an important role not only in diagnosing the disease, but also representing the pathogenesis of the disease. ANA is the main screening tool in diagnosis and serum complement levels and anti-dsDNA antibody level are closely related to the disease activities.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: